ustekinumab-auub

Generic: Wezlana

45 mg/0.5 mL, 90 mg/mL — Vial

TARGETED IMMUNOMODULATORY BIOLOGICS

Also known as: WEZLANA

Coverage by Insurer

Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Source: CMS QHP JSON  ·  Formulary date: Mar 18, 2026  ·  Checked: 14 hours, 28 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
Provider Partners North Carolina Advantage Plan (HMO I-SNP)
via Wezlana
Tier 1 - Preferred Generic 3 per 84 days PA | QL
Provider Partners North Carolina Essential Plan (HMO I-SNP)
via Wezlana
Tier 1 - Preferred Generic 3 per 84 days PA | QL
Provider Partners North Carolina Community Plan (HMO I-SNP)
via Wezlana
Tier 1 - Preferred Generic 3 per 84 days PA | QL
HealthTeam Advantage Plan II (PPO)
via Wezlana
Tier 5 - Specialty 3 per 84 days PA | QL
HealthTeam Advantage Plan I (PPO)
via Wezlana
Tier 5 - Specialty 3 per 84 days PA | QL
HealthTeam Advantage Vitality Plan (PPO)
via Wezlana
Tier 5 - Specialty 3 per 84 days PA | QL
HealthTeam Advantage Diabetes & Heart Care (HMO C-SNP)
via Wezlana
Tier 5 - Specialty 3 per 84 days PA | QL
Source: PDF  ·  Formulary date: Apr 1, 2026  ·  Checked: 14 hours, 28 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
NC State Health Plan - 80/20 Plus PPO 2026
via Wezlana
Not Covered None
NC State Health Plan - HDHP 2026
via Wezlana
Not Covered None
NC State Health Plan - 70/30 Standard PPO 2026
via Wezlana
Not Covered None
Source: Excel (XLSX)  ·  Formulary date: Jan 5, 2026  ·  Checked: 14 hours, 28 minutes ago
Plan Tier Prior Auth Step Therapy Quantity Limit Restrictions
TRICARE Uniform Formulary 2026 Tier 3 - Non-Formulary PA
Something not right?